15 results
·
29ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
SYMPHONY OCT System
FDA 510(k)
FDA Class 2
·Orthopedic
MSI Precision Specialty Instruments
FDA UDI
Med Saver, Inc.·00194613103224·McCulloch Retractor, 4 Black Teeth, 90mm Long B...
MSI Precision Specialty Instruments
FDA UDI
Med Saver, Inc.·00194613105556·McCulloch Retractor, 6 Black Teeth, 120mm Long ...
MSI Precision Specialty Instruments
FDA UDI
Med Saver, Inc.·00194613105525·McCulloch Retractor, 6 Black Teeth, 90mm Long B...
MSI Precision Specialty Instruments
FDA UDI
Med Saver, Inc.·00194613105532·McCulloch Retractor, 6 Black Teeth, 100mm Long ...
PEDIATRIC BODY-CARDIAC COIL, MODEL: 5000012601
FDA 510(k)
FDA Class 2
·Radiology
AC WOUND TREATMENT SYSTEM
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
MSI Precision Specialty Instruments
FDA UDI
Med Saver, Inc.·00194613103262·McCulloch Retractor, 4 Black Teeth, 120mm Long ...
MSI Precision Specialty Instruments
FDA UDI
Med Saver, Inc.·00194613103231·McCulloch Retractor, 4 Black Teeth, 100mm Long ...
SEE H10 NARRATIVE
FDA Adverse Event
Injury
·ZIMMER BIOMET, INC.·Product code JWH·May 16, 2023
SECURA DR
FDA Adverse Event
Death
·MEDTRONIC MED REL, INC.·Product code LWS·July 28, 2011
LD304 MATERNITY BED
FDA Adverse Event
Malfunction
·STRYKER MEDICAL-KALAMAZOO·Product code HDD·June 21, 2013
ACCU-CHEK COMFORT CURVE TEST STRIPS
FDA Adverse Event
Malfunction
·ROCHE DIAGNOSTICS CORP.·Product code LFR·September 22, 2008
Vantage Total Ankle System including a. Vantage Fixed-Bearing Polyethylene Liner Component (Product Line: 350-21-XX, 350-22-XX); b. Vantage Mobile-Bearing Polyethylene Liner Component (Product Line: 350-41-XX, 350-42-XX). NOTE: Information reflects Exactech recall expansion initiated on 02/07/2022.
FDA Enforcement
Class II
·Ongoing·Exactech, Inc.·October 13, 2021
Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014